200 likes | 322 Views
Update on WHO GAVI European Regional Working Group and hepatitis B Immunization. Viral Hepatitis Prevention Board Meeting 7-8 November 2002 Catania, Italy. Reported immunization coverage rate WHO/EURO, 1990-2001. >95%. 90-95%. 80-90%. <80%. no data reported.
E N D
Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting 7-8 November 2002 Catania, Italy
>95% 90-95% 80-90% <80% no data reported 1991 Coverage for DTP3/OPV3 vaccine at 12 months of age Administrative data: 1991 Cisid >80 %
>95% 90-95% 80-90% <80% no data reported 2001 Coverage for DTP3/OPV-IPV3 vaccine at 12 months of age Administrative data: 2001 Joint Reporting Form
Introduction of new/under-utilized vaccines • Substantial progress in introducing HepB • 41 countries already included into routine immunization programme • 37 infant & routine • 4 adolescent • Hib; widely used in W. Europe, limited in other areas • Need for burden assessment • Improvement in implementation
Hep B immunization programmes, WHO European Region, 2002 Routine infant Routine newborn Adolescent only Selective HepB immun..
Reported DTP3 and HepB3 coverage WHO/EURO, 2001 Data from JRF
Objectives of GAVI Immunization is the right of every child to be protected against VPDs • Improve access to sustainable immunization services • Expand use of all existing vaccines • Accelerate research and development of vaccines, with special focus to developing country needs • Immunization an integral part of health systems and international development
GAVI Vaccine Fund support * new and under-used vaccines • Hep B • Hib • Yellow fever; bundled with safety equipment * immunization services support * injection safety support
Immunization services and injection safety DTP3 coverage <50% Basic Conditions GNP/capita < US$1000 ICC or equivalent Immunization assessment in last 3 years Multi-year plan for Immunization Injection safety strategy Immunization services, new and under-used vaccines and injection safety DTP3 coverage 50% - 80% New and under-used vaccines and injection safety DTP3 coverage >80% What will the FUND finance ?
Albania Armenia Azerbaijan Bosnia & Herzegovina Georgia Kyrgyzstan Moldova Tajikistan Turkmenistan Ukraine Uzbekistan Countries eligible for support from the GAVI Vaccine FundEleven out of 51 countries:
Status of country applications for GAVI / VF support, October 2002
Status of HepB introduction in GAVI / VF eligible countries (# 1)
Status of HepB introduction in GAVI / VF eligible countries (# 2)
GAVI related activities WHO/EURO • Immunization and cold chain reviews • Disease burden assessments • Planning • Multi-year national immunization plans including new vaccine introduction • Safety of immunization • Financial sustainability • Implementation • Training at national and subnational levels • Supervision • Coordination • National ICCs
GAVI related activities WHO/EURO Monitor progress • Annual progress reports and joint reporting from • Data quality audits • Subregional immunization programme managers meetings • St Petersburg 2001 • Vienna 2002 • Kyiv 2003 (planned) • Expansion to other countries • policies and strategies • training programmes and material • support for vaccine procurement
European GAVI Regional Working Group • Established and regularly met since 2001 • Members:WHO, UNICEF, World Bank, CVP/PATH, Vaccine Fund, VHPB and CDC/Atlanta • Coordinate GAVI partners’ support and activities • Ensure timely and appropriate technical and financial support to countries • Identify needs for strengthening immunization services and capacities for introduction of new vaccines • Strengthen National ICCs • Provide input to the Regional ICC
GAVI initiative and lessons learnedWHO European Region • Opportunity for accelerating new vaccine introduction • Impact on strengthening immunization services • programme assessments • multi-year immunization plans • resource mobilization, coordination (national ICCs) • emphasis on injection safety • Expand infrastructure, build capacity • Access (80/80 district goal) • Apply lessons learned to other countries
Areas for future action • Strengthen immunization service delivery • Provide policy guidelines • Use national multi-year plans as a managerial tool • Monitor implementation/exchange information • Support mid-term reviews and development of FSP • Technical support for Hib burden assessments • Support training, also for introduction of new vaccines • Apply lessons learned/experience gained to “non-GAVI” countries